SEC Form 4 · accession 0000891293-15-000042
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard L Love
Director
Period of report
Sep 23, 2015
Accepted (ET)
Sep 25, 2015 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Sep 23, 2015 | A | 63,695 | A | — | — | Common Stock | 63,695 | 63,695 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock.
- F2These restricted stock units are scheduled to vest on the date that is twelve months after the date of grant or, if earlier, the first annual meeting of CTIC's shareholders in 2016 at which one or more members of the CTIC Board of Directors are to be elected.